Amanita mushroom gummies are not considered safe for teens simply because they are sold as “legal psychedelics,” mushroom supplements, or alternatives to psilocybin. These products may contain muscimol, ibotenic acid, or other substances that can cause unpredictable effects, including poisoning and serious neurological symptoms.
The term Amanita mushroom gummies generally refers to edible products marketed as containing compounds from Amanita muscaria, a mushroom commonly known as fly agaric. Unlike psilocybin-containing mushrooms, Amanita muscaria contains muscimol and ibotenic acid, which act differently in the brain and can produce a different pattern of intoxication.
The concern is not limited to the mushroom itself. Products marketed as psychedelic or nootropic mushroom edibles may have inaccurate labels or contain substances that are not disclosed. The U.S. Food and Drug Administration (FDA) has warned that Amanita muscaria, its extracts, and certain constituents are not authorized for use as ingredients in conventional food in the United States and may be harmful. The agency recommends avoiding foods containing these ingredients.[1]
For teenagers, the combination of uncertain ingredients, unpredictable effects, and limited safety evidence makes these products a particular concern.
What Are Amanita Mushroom Gummies?
Amanita mushroom gummies are edible products marketed as containing Amanita muscaria, mushroom extracts, or compounds associated with the mushroom. They may be promoted as “legal psychedelic edibles,” “mushroom gummies,” “nootropic gummies,” or alternatives to traditional psychedelic mushrooms.
The primary psychoactive compounds associated with Amanita muscaria are muscimol and ibotenic acid. These compounds affect the central nervous system and can contribute to effects such as sedation, altered perception, confusion, agitation, and other neurological symptoms. Muscarine is also associated with Amanita muscaria, but it is not considered the main compound responsible for its characteristic psychoactive effects. The FDA’s review of Amanita muscaria and its constituents discusses the compounds and potential health effects associated with exposure.[3]
Unlike psilocybin, muscimol and ibotenic acid act through different neurological pathways. The FDA’s review describes reported effects of Amanita-related exposure, including gastrointestinal symptoms, delirium, sleepiness, alternating periods of drowsiness and excitement, and, with large exposures, severe neurological effects such as seizures and coma.[3] Read the FDA’s assessment of Amanita-related food safety concerns.
A gummy’s label may not clearly establish which compounds are present or how much of each it contains. In a 2024 CDC investigation of mushroom gummies, laboratory testing found that some products marketed as containing Amanita or other mushroom ingredients also contained undisclosed substances, including psilocybin and psilocin.[2] This finding shows why a product’s marketing description or label should not be treated as a reliable account of its actual ingredients or pharmacological effects.
Are Amanita Mushroom Gummies Legal?
The word “legal” on a product label does not establish that the product is safe, approved, or legal in every jurisdiction.
In the United States, the FDA has stated that Amanita muscaria, its extracts, muscimol, ibotenic acid, and muscarine are not authorized for use as ingredients in conventional food. The agency has also warned that available evidence indicates potential harm.[1]
State and local rules may also differ, and the legal status of a product can depend on its ingredients, formulation, labeling, and intended use. A product being sold in a store or online does not establish that it meets applicable safety or regulatory requirements.
For parents, the practical distinction is important: legal availability is not the same as demonstrated safety, especially for adolescents.
How Do Amanita Mushroom Gummies Affect the Brain and Body?
Amanita mushroom gummies may affect the central nervous system because of compounds such as muscimol and ibotenic acid. The resulting effects can vary with the product’s actual ingredients, amount consumed, individual sensitivity, and whether other substances were taken.
Possible effects include:
- Drowsiness or unusual sleepiness: Muscimol affects inhibitory signaling in the central nervous system and may cause sedation, excessive sleepiness, reduced alertness, or difficulty staying awake. In more serious cases, a person may become difficult to awaken.
- Confusion or disorientation: Amanita-related intoxication may affect awareness, attention, and the ability to understand surroundings. A person may appear confused, have trouble following conversations, respond inappropriately, or become disoriented about their location or situation.
- Altered perception or hallucinations: Some people may experience changes in sensory perception, unusual visual experiences, or hallucinations. These effects can occur alongside confusion or changes in mental status. They are not necessarily predictable and can be distressing.
- Anxiety, agitation, or unusual behavior: Exposure may cause restlessness, agitation, excitement, or unpredictable changes in behavior. Some people may alternate between periods of drowsiness and heightened activity. These changes can make it difficult to communicate with or safely supervise an intoxicated person.
- Dizziness or impaired coordination: Neurological effects may interfere with balance, movement, and coordination. A person may feel unsteady, stumble, have difficulty walking, or struggle with tasks requiring controlled movements. These effects can increase the risk of falls and accidental injuries.
- Nausea, vomiting, or other gastrointestinal symptoms: Amanita-related exposure can cause nausea, vomiting, abdominal discomfort, and other gastrointestinal symptoms. Persistent vomiting can contribute to dehydration and may require medical attention, particularly in children and adolescents.
- Changes in heart rate or blood pressure: Some reported cases involving mushroom gummies have included increased heart rate and other cardiovascular symptoms. However, these effects are not specific to Amanita compounds, and the actual ingredients in a product may influence the reaction. A rapid or irregular heartbeat, chest pain, or fainting warrants prompt medical assessment.
- Seizures or loss of consciousness in severe cases: Serious Amanita-related poisoning can involve seizures, profound changes in consciousness, or coma. The FDA has also reported serious adverse events associated with Amanita-related products, including respiratory depression. Seizures, loss of consciousness, difficulty breathing, or an inability to awaken someone require immediate emergency medical care.
The type and severity of symptoms depend on the product’s actual ingredients, the amount consumed, individual sensitivity, and possible interactions with other substances. Because these effects can overlap with symptoms of other forms of poisoning, suspected ingestion should be assessed by a poison specialist or healthcare professional rather than diagnosed based on symptoms alone.
Muscimol and ibotenic acid are two compounds associated with the effects of Amanita muscaria. Muscimol acts on GABA-A receptors, which are involved in inhibitory signaling in the central nervous system. Ibotenic acid has activity at glutamate receptors and may contribute to neurological excitation.
Their different actions help explain why Amanita exposure can cause varied effects, including drowsiness, confusion, agitation, hallucinations, and seizures. The severity and combination of symptoms can vary by product, dose, and individual response. The FDA has also reported adverse events associated with Amanita-related products, including seizures, respiratory depression, and coma.[1]
These effects should not be interpreted as a predictable checklist. A person may experience only mild symptoms, while another may develop a severe reaction. The absence of immediate symptoms also does not prove that a product is safe.
Why Are “Legal Psychedelic” Edibles a Concern for Teens?
Amanita gummies raise concerns for adolescents because their ingredients, potency, and effects may be uncertain, making the risks of exposure difficult to predict.
Uncertain Ingredients and Potency
A product marketed as an Amanita gummy may not contain only the ingredients listed on its label. In a 2024 CDC investigation of five brands of mushroom gummies, researchers analyzed products marketed as containing Amanita muscaria or other mushroom ingredients. Three brands contained unlabeled psilocybin or psilocin. Investigators also detected other substances, including caffeine, ephedrine, and mitragynine, in some products. These findings highlight the possibility that the actual ingredients in some mushroom gummies may differ from their labels.[2]
This investigation does not establish that every Amanita gummy is adulterated. It does demonstrate that product labels may not accurately represent the substances inside some mushroom edibles.
For a teenager, an unexpected ingredient can create additional risks, particularly when the product is taken with medications, alcohol, cannabis, or other substances.
Unpredictable Intoxication
Amanita-related compounds affect the brain differently from psilocybin. Their effects may include sedation, confusion, agitation, hallucinations, and impaired coordination. A teen who expects a mild or manageable experience based on product marketing may instead experience significant intoxication or poisoning.
The amount stated on the package may not reliably predict the actual exposure if the product is inaccurately labeled or inconsistently manufactured.
Limited Safety Evidence
The FDA reviewed more than 600 scientific publications during its assessment of Amanita muscaria and related compounds. In its letter to industry on the use of Amanita muscaria or its constituents in food, the agency concluded that the available evidence was insufficient to establish the safety of these substances as conventional food ingredients and indicated potential health risks.[3]
This is particularly relevant to teenagers. A lack of adequate safety evidence should not be interpreted as proof that an edible is harmless or appropriate for adolescent use.
Possible Effects on School, Relationships, and Daily Functioning
Intoxication can interfere with attention, judgment, coordination, and the ability to respond appropriately to everyday situations. Repeated use may also become a concern when a teen uses psychoactive products to cope with stress, emotional distress, or other difficulties.
A single episode of use does not automatically establish a substance use disorder. However, recurring use, difficulty stopping, continued use despite harmful effects, or noticeable changes in a teen’s daily functioning are reasons to consider a professional assessment.
Can Amanita Mushroom Gummies Cause Poisoning?
Yes. Amanita mushroom gummies can cause poisoning, particularly when they contain muscimol, ibotenic acid, or other undisclosed psychoactive substances.
Reported symptoms of Amanita-related poisoning include gastrointestinal distress, altered mental status, drowsiness, agitation, hallucinations, abnormal heart rate, seizures, and, in severe cases, coma or respiratory depression.[1][3]
The risk can be difficult to assess because the product’s actual composition and the amount consumed may be unknown. Products sold under similar names may also have different formulations.
A 2024 investigation by the CDC described five people who required hospital evaluation after consuming mushroom gummies labeled as containing Amanita muscaria. Reported symptoms included increased heart rate, confusion, anxiety, sleepiness, nausea, and chest pain. One child was hospitalized after accidentally ingesting two gummies.[2]
These cases do not predict how every exposure will unfold. They do show why a suspected ingestion should be taken seriously, particularly when a child or teenager is involved.
What Are the Signs of Amanita Mushroom Gummy Poisoning?
Symptoms can vary depending on the substance involved and the severity of exposure. Possible warning signs include:
| Symptom | Why it matters |
|---|---|
| Unusual sleepiness or difficulty staying awake | May indicate central nervous system depression. |
| Confusion or disorientation | Can signal significant intoxication or altered mental status. |
| Agitation or unusual behavior | May occur with neurological excitation or an adverse reaction. |
| Hallucinations or severe changes in perception | Can indicate a significant psychoactive reaction. |
| Nausea or repeated vomiting | May occur with mushroom-related poisoning and can lead to dehydration or other complications. |
| Rapid or irregular heartbeat | May indicate cardiovascular effects that need medical assessment. |
| Seizures | A medical emergency requiring immediate care. |
These symptoms are not unique to Amanita exposure. Other substances and medical conditions can produce similar signs. A healthcare professional or poison specialist may need details about the product, timing, symptoms, and possible co-ingestions to assess the situation.
Seek emergency medical care immediately if a teen has a seizure, loses consciousness, cannot be awakened, has difficulty breathing, develops severe confusion, or experiences another severe or rapidly worsening reaction. Do not wait for symptoms to become more severe.
What Should Parents Do If a Teen Takes Amanita Mushroom Gummies?
If a teen is suspected of consuming Amanita mushroom gummies, the first step is to check for signs of a medical emergency. Emergency services should be contacted immediately if the teen experiences a seizure, difficulty breathing, loss of consciousness, severe confusion, or another serious or rapidly worsening symptom.
If the teen is awake and does not show severe symptoms, a poison control center should be contacted promptly for advice. Medical guidance should not be delayed until symptoms become severe, as the product’s actual ingredients and the amount consumed may be uncertain. In the United States, Poison Control is available at 1-800-222-1222.
The product packaging, if available, should be kept and shared with medical professionals, along with details about the product, the estimated amount consumed, and the time of ingestion. Vomiting should not be induced, and home remedies should not be attempted unless specifically recommended by a medical professional. All further instructions from Poison Control or the treating medical team should be followed.
How Can Parents Talk to Teens About Legal Psychedelic Edibles?
A calm, direct conversation can help parents understand why a teen tried Amanita gummies and whether further support may be needed.
Rather than starting with accusations or punishment, ask what the teen believed the product contained, where it came from, and what effects they experienced. Some teens may assume that products sold openly in stores or promoted on social media are safe. Others may be curious about altered perception or may use psychoactive products in response to stress, anxiety, or social pressure.
It may help to explain that “legal,” “natural,” and “mushroom-based” are marketing descriptions, not proof of safety. The FDA has specifically warned that Amanita-related ingredients may be harmful when used in conventional food, and public health investigations have identified undisclosed substances in some mushroom gummies.[1][2]
Pay attention to patterns rather than drawing conclusions from one incident. Repeated use, cravings, difficulty stopping, hiding use, declining school performance, changes in relationships, or continued use despite negative consequences may indicate that professional evaluation would be useful.
If a teen is willing to talk, listen without assuming that the product’s label accurately describes what they consumed. A pediatrician, mental health professional, or substance-use treatment provider can help assess the situation and identify appropriate next steps.
Teen Substance Use Treatment at Clearfork Academy
When a teenager repeatedly uses Amanita gummies or other psychoactive substances, professional support can help determine whether the behavior has progressed beyond experimentation or occasional use.
Clearfork Academy provides substance-use and mental-health treatment for adolescents ages 13–17, including teens with co-occurring mental health or behavioral concerns. Its treatment options include residential treatment, Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP), and Virtual IOP. The appropriate level of care depends on the teen’s clinical needs.
Treatment may address substance use and underlying concerns through individual, group, and family therapy, along with approaches such as Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT).
Clearfork Academy works with insurance to help eligible families access adolescent mental-health and substance-use treatment. Coverage and out-of-pocket costs vary by plan, benefits, diagnosis, and level of care. Families can contact Clearfork Academy to verify their insurance coverage and discuss available treatment options.
A professional assessment can help determine whether a teen has a substance use disorder, whether co-occurring concerns are present, and what level of care may be appropriate.
Frequently Asked Questions
Q. Are Amanita mushroom gummies safe for teens?
No. Amanita mushroom gummies have not been established as safe for teenagers. They may contain psychoactive compounds such as muscimol and ibotenic acid, which can cause intoxication, confusion, gastrointestinal symptoms, seizures, and other serious effects. The FDA has warned that these ingredients may be harmful when used in conventional food.[1]
Q. Are Amanita mushroom gummies the same as magic mushroom gummies?
No. Amanita gummies are generally marketed as containing Amanita muscaria or related compounds such as muscimol. Traditional “magic mushrooms” typically refer to psilocybin-containing mushrooms. These substances have different chemical properties and effects. However, some mushroom gummies marketed as Amanita or nootropic products have been found to contain undisclosed psilocybin or other substances.[2]
Q. Can Amanita mushroom gummies cause hallucinations?
Yes. Amanita-related compounds can alter perception and may cause hallucinations, confusion, or other changes in mental status. The effects vary by exposure and product composition. Hallucinations accompanied by severe confusion, agitation, loss of consciousness, or other concerning symptoms warrant urgent medical assessment.[1][3]
Q. Are Amanita gummies legal in the United States?
The legal status of Amanita gummies depends on their ingredients, formulation, and the laws that apply in the place where they are sold or used. In the United States, the FDA has stated that Amanita muscaria and certain related compounds are not authorized for use as ingredients in conventional food. A product being openly sold does not, by itself, establish that it complies with applicable requirements or is safe to consume.[1]
Q. What happens if a teen accidentally eats Amanita mushroom gummies?
A teen may experience nausea, vomiting, unusual sleepiness, confusion, agitation, altered perception, or other symptoms. Severe poisoning can involve seizures, loss of consciousness, or breathing problems. Contact Poison Control or a healthcare professional promptly after a suspected ingestion. Call 911 for severe or rapidly worsening symptoms.
Q. Can Amanita mushroom gummies show up on a drug test?
Routine drug screens may not detect muscimol or ibotenic acid. Detection depends on the substances involved and the specific testing method. Some mushroom gummies have also been found to contain other drugs that may have different detection profiles.[2] A negative routine drug screen does not establish that a teen did not consume a mushroom edible.
Q. Can a teen develop a substance use problem from Amanita gummies?
Repeated use of psychoactive mushroom edibles may become a concern, especially when a teen has difficulty stopping, continues using despite harmful effects, or uses substances to cope with emotional distress. The available evidence does not establish a specific pattern or rate of Amanita gummy dependence in adolescents. A professional assessment can help determine whether substance use or other mental health concerns require treatment.
Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Suspected poisoning or serious symptoms after consuming Amanita mushroom gummies require prompt medical evaluation.
References
- U.S. Food and Drug Administration. FDA Alerts Industry and Consumers about the Use of Amanita Muscaria or its Constituents in Food. December 18, 2024.
- Centers for Disease Control and Prevention. Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms. July 18, 2024.
- U.S. Food and Drug Administration. Letter to Industry on the Use of Amanita Muscaria or its Constituents in Food.
Shelby Hartman is a Licensed Master Social Worker with specialized training in EMDR (Eye Movement Desensitization and Reprocessing). She brings over a decade of experience in behavioral health, beginning her career as a Behavioral Health Technician at John Peter Smith Hospital’s Psychiatric Emergency Center, where she served for nine years supporting individuals in acute crisis.
She has also contributed to the community through volunteer work with Safe Haven in the Dallas–Fort Worth area, supporting survivors of domestic violence. She earned her Master of Social Work degree from Chamberlain University and went on to work as an inpatient program therapist for over two years, providing intensive therapeutic care to adolescents. Currently serving at Clearfork Academy, Shelby continues her work with teens navigating mental health challenges and substance use.
